Clinical Trials Browser

Phase 3 × Terminated × ARQ 197 × Clear all

NCT01244191 2021-04-06

Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung Cancer

Phase 3 Terminated

1,048 enrolled 15 charts

Carcinoma, Non-Small-Cell Lung

NCT01377376 2016-12-07

ATTENTION

Phase 3 Terminated

Carcinoma, Non-Small-Cell Lung